NEW YORK, NY / ACCESSWIRE / April 28, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided.
Corcept Therapeutics Incorporated (CORT)
Class Period: August 2, 2017 - February 5, 2019
Lead Plaintiff Deadline : May 13, 2019
Join the action: https://www.zlk.com/pslra-1/corcept-therapeutics-incorporated-loss-form?prid=1295&wire=1
About the lawsuit: Corcept Therapeutics Incorporated allegedly made materially false and/or misleading statements during the class period and/or failed to disclose that: (1) the Company had improperly paid doctors to promote its drug Korlym; (2) the Company aggressively promoted Korlym for off-label uses; (3) the Company's sole specialty pharmacy was a related party; (4) the Company artificially inflated its revenue and sales using illicit sales practices through a related party; (5) such practices are reasonably likely to lead to regulatory scrutiny; and (6) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
To learn more about the Corcept Therapeutics Incorporated class action contact email@example.com.
Syneos Health, Inc. (SYNH)
Class Period: May 10, 2017 - February 27, 2019
Lead Plaintiff Deadline : April 30, 2019
Join the action: https://www.zlk.com/pslra-1/syneos-health-inc-loss-form?prid=1295&wire=1
About the lawsuit: Throughout the class period, Syneos Health, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Syneos Health's internal control over financial reporting was inadequate; (2) concerns regarding Syneos Health's internal control over financial reporting would result in heightened regulatory scrutiny and an SEC investigation into the company's revenue accounting policies, internal controls and related matters; and (3) as a result, defendants' statements about Syneos Health's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.
To learn more about the Syneos Health, Inc. class action contact firstname.lastname@example.org.
Bridgepoint Education Inc. (BPI)
Class Period: March 8, 2016 - March 7, 2019
Lead Plaintiff Deadline : May 10, 2019
Join the action: https://www.zlk.com/pslra-1/bridgepoint-education-inc-loss-form?prid=1295&wire=1
About the lawsuit: During the class period, Bridgepoint Education Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Bridgepoint's processes for recording revenue for its FTG program were inaccurate; (ii) Bridgepoint maintained deficient internal controls; (iii) due to the foregoing deficiencies, Bridgepoint was prone to and did commit material accounting errors related to revenue, provision for bad debts, accounts receivable and deferred revenue, which resulted in the overstatement of revenue and expenses; and (iv) as a result, Bridgepoint's public statements were materially false and misleading at all relevant times.
To learn more about the Bridgepoint Education Inc. class action contact email@example.com.
You have until the lead plaintiff deadlines to request the court appoint as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: Levi & Korsinsky, LLP
View source version on accesswire.com: